Ophthalmology
1 drug is in development for Ocular Hypertension.
- Companies
- 1
- Clinical trials
- 14
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Ocular Hypertension pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| sbi-100 ophthalmic emulsion | Skye Bioscience, Inc. (SKYE) |
About this indication
Ocular Hypertension context
Ophthalmology·MeSH: Ocular Hypertension (D009798)
Also known as: Hypertensions, Ocular
Prevalence
47000.0 / 100K
Incidence
3000.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Ocular Hypertension?
BioSniper tracks 1 drug in development for Ocular Hypertension across 1 company.
How many clinical trials target Ocular Hypertension?
There are 14 clinical trials targeting Ocular Hypertension tracked by BioSniper.
What is the prevalence of Ocular Hypertension?
The estimated prevalence of Ocular Hypertension is approximately 47000.0 per 100,000 population.